AMHR2 Gene Persistent Mullerian duct syndrome type 2 Genetic Test
Are you looking for information on the AMHR2 Gene Persistent Mullerian duct syndrome type 2 Genetic Test? Look no further! DNA Labs UAE is here to provide you with all the details you need.
Test Name: AMHR2 Gene Persistent Mullerian duct syndrome type 2 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Reproductive Disorders
Doctor: Gynecology
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for AMHR2 Gene Persistent Mullerian duct syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AMHR2 Gene Persistent Mullerian duct syndrome type 2 NGS Genetic DNA Test gene AMHR2
Test Details
The AMHR2 gene (Anti-Mullerian Hormone Receptor Type 2) is associated with a condition called Persistent Mullerian Duct Syndrome (PMDS) type 2. PMDS is a rare genetic disorder that affects sexual development in individuals with XY chromosomes. PMDS type 2 occurs when individuals with XY chromosomes have mutations or variations in the AMHR2 gene.
This gene provides instructions for making a protein called anti-Mullerian hormone receptor type 2, which is involved in the development of male reproductive organs. Individuals with PMDS type 2 have a normal male genotype (XY) but may have female or ambiguous external genitalia. This is because the anti-Mullerian hormone receptor type 2 protein is not functioning properly, leading to the persistence of female reproductive structures (Mullerian ducts) and incomplete masculinization of the external genitalia.
NGS (Next-Generation Sequencing) genetic testing can be used to analyze the AMHR2 gene and identify any mutations or variations that may be associated with PMDS type 2. This type of genetic test involves sequencing the entire gene to identify any changes in the DNA sequence. By identifying specific mutations or variations in the AMHR2 gene, NGS genetic testing can provide a definitive diagnosis of PMDS type 2.
This information can be helpful in understanding the underlying cause of the condition, predicting the potential for reproductive issues, and guiding appropriate medical management and counseling for affected individuals and their families.
Test Name | AMHR2 Gene Persistent Mullerian duct syndrome type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Reproductive Disorders |
Doctor | Gynecology |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for AMHR2 Gene Persistent Mullerian duct syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AMHR2 Gene Persistent Mullerian duct syndrome type 2 NGS Genetic DNA Test gene AMHR2 |
Test Details |
The AMHR2 gene (Anti-Mullerian Hormone Receptor Type 2) is associated with a condition called Persistent Mullerian Duct Syndrome (PMDS) type 2. PMDS is a rare genetic disorder that affects sexual development in individuals with XY chromosomes. PMDS type 2 occurs when individuals with XY chromosomes have mutations or variations in the AMHR2 gene. This gene provides instructions for making a protein called anti-Mullerian hormone receptor type 2, which is involved in the development of male reproductive organs. Individuals with PMDS type 2 have a normal male genotype (XY) but may have female or ambiguous external genitalia. This is because the anti-Mullerian hormone receptor type 2 protein is not functioning properly, leading to the persistence of female reproductive structures (Mullerian ducts) and incomplete masculinization of the external genitalia. NGS (Next-Generation Sequencing) genetic testing can be used to analyze the AMHR2 gene and identify any mutations or variations that may be associated with PMDS type 2. This type of genetic test involves sequencing the entire gene to identify any changes in the DNA sequence. By identifying specific mutations or variations in the AMHR2 gene, NGS genetic testing can provide a definitive diagnosis of PMDS type 2. This information can be helpful in understanding the underlying cause of the condition, predicting the potential for reproductive issues, and guiding appropriate medical management and counseling for affected individuals and their families. |